While both whole exome sequencing (WES) and whole genome sequencing (WGS) interrogate all genes in the human genome, WGS is more comprehensive in the variant classes it can identify. This type of genetic diagnosis allows for tailored medical management and treatment guidance for patients. Studies have shown that around 20% of patients had direct changes to care based on WES or WGS results.
Mayo Clinic Laboratories’ whole exome and whole genome testing is backed by a team of experienced laboratory directors, genetic counselors, and variant scientists. Test results are interpreted by this collaborative team, who consider previous evaluations and test results from genetic studies, biochemical testing, and imaging studies as part of the genetic data review. Genetic disease experts are available to answer questions about test findings or the need for additional testing.
Fill out the form below and one of our specialists will be in touch.